The 29 Percent Signal: Revenue Concentration Risk in Your Dental Group

The insurance exit wave of 2025 did not create a revenue problem for dental groups. It revealed one that was already there.

Across the groups in The Dental Index national practice audit that moved locations out of network last year, a pattern appeared with striking consistency. Locations that held their patient base shared one characteristic: their patients knew exactly what they were choosing and had made that choice for reasons that had nothing to do with price. Locations that lost a significant share of their active patient volume shared a different characteristic: the value proposition was the insurance contract. Take that away, and the loyalty went with it.

This is not a fee schedule problem. It is a positioning problem. And it is sitting inside your current portfolio whether you have exited insurance networks or not.

Is Your Patient Revenue More Concentrated Than Your Portfolio Model Assumes?

Every multi-site group runs revenue projections by location: collections, payer mix, procedure codes, hygiene recall rate. What those models rarely capture is the revenue concentration risk that comes from a patient base built around insurance access rather than clinical preference.

When a patient chooses your practice because it is in-network, they have not chosen your practice. They have chosen the path of least resistance. Those patients will stay as long as the friction of leaving is higher than the friction of staying. Change the fee structure, and you find out exactly how many of your active patients were loyal to the network, not to you.

The Dental Index national practice audit found that the average practice leaves $147,000 in annual production unrealised: not from empty chairs, but from a case mix that does not match the positioning the practice has built. Your group's unrealised production gap scales with your location count. At 15 locations, that is a material EBITDA variance sitting in your portfolio today. And most of it does not appear on your standard performance dashboard.

The question is not whether your patient base has concentration risk. It almost certainly does. The question is whether you can see it before a transition event forces it into view.

What Is the Insurance Exit Data Actually Telling You About Your Locations?

The locations that lost the most patients after exiting insurance networks were not the ones with the highest fees. They were the ones with the least distinctive positioning in their local market.

Patients who leave when a practice goes out of network are not price-sensitive in some general sense. They are price-sensitive specifically to that practice, because they had no other reason to stay. If a location had built a recognisable clinical identity, a reputation for a specific service, a patient community that talked about it to colleagues and neighbors, those patients absorb the fee change as a cost of access to something they already wanted. If the location had built nothing except convenience and a contracted rate, there was nothing to absorb.

The Dental Index data shows implant demand growing at 8.5 percent per year nationally, with average case values at $4,500. Cosmetic demand is growing at 6.8 percent per year at $3,800 average case value. These are categories where patients are already motivated to spend. They are searching for a practice worth choosing. Your locations competing for this demand need a reason for patients to choose them beyond the insurance list.

If you have locations with strong hygiene recall volume but flat or declining implant and cosmetic case acceptance, that is a positioning signal. Those patients are returning for preventive care because it is covered. They are not choosing elective procedures from you because they have not been given a clear reason to. Your case mix problem is not a clinical problem. It is a positioning gap showing up in your procedure codes.

What Does Revenue Concentration Look Like Inside a Multi-Site Portfolio?

Revenue concentration in a dental group typically shows up in one of three forms. Look for these patterns in your own data before a network transition makes them visible in a less comfortable way.

• Payer concentration: Two or three insurance contracts account for 60 percent or more of collections across multiple locations. Any change at any of those contracts becomes a portfolio-level revenue event, not a single-location problem.
• Procedure concentration: Collections are dominated by preventive and restorative codes while implant, cosmetic, and orthodontic production sits well below the demand levels in each local market. The location is capturing maintenance spend, not investment spend.
• Location concentration: Two or three locations generate a disproportionate share of group EBITDA while the remaining locations drag on aggregate performance. The outperformers are almost always the ones with the clearest clinical identity in their specific market.

All three forms share the same root cause. The positioning at those locations has not been built clearly enough for a patient to understand what they are choosing when they choose you over the practice down the street.

Look at the locations in your portfolio with the highest EBITDA margin. Then look at the ones at the bottom. The difference is almost never clinical quality. It is how clearly each location's positioning meets the specific demand profile of its local market.

What Are the Groups Getting This Right Doing Differently?

The groups in The Dental Index data with the lowest revenue concentration risk share a set of observable patterns. These are not portfolio-wide initiatives. They are operational decisions made at the location level, based on a clear understanding of what each market's demand profile actually supports.

• Location-level clinical identity: Each location has a defined clinical emphasis that matches demonstrable demand in its specific market. Not brand-wide positioning applied uniformly across every ZIP code. Local positioning built from local demand data and local income demographics.
• Case mix aligned with the market ceiling: Locations in high-income markets run a different procedure mix than locations in density-driven, price-sensitive markets. The fee structure and service emphasis tracks the income and demand profile of the ZIP code, not a group-wide template that ignores what the local market can actually support.
• Elective revenue above 30 percent of collections: In the locations performing at the top of the EBITDA range, elective and high-value procedures account for a material share of production. These locations are not dependent on insurance volume to sustain performance. They can weather a network change without losing their patient base.
• Patient acquisition driven by positioning clarity: New patients at high-performing locations are more likely to arrive having already searched for specific procedures or clinical outcomes. They have decided what they want to invest in before the first call. The consultation confirms rather than creates the buying decision.

The Dental Index national practice audit found that AI-referred patients book high-value procedures at 2 to 3 times the rate of patients from other referral sources. Your highest-value patients in 2026 are finding practices through Google Maps and AI search before they ever call the front desk. If your locations are not visible in those channels for the procedures you are trying to grow, you are not competing for those patients regardless of how clearly your positioning is stated in your internal brand documents.

Revenue concentration is what happens when your patient base chose your network access, not your clinical positioning.

How Long Before Positioning Changes Show Up in Your Portfolio EBITDA?

Positioning changes at the location level take six to nine months to appear clearly in case mix data. The mechanism is straightforward: as positioning becomes more distinct at a location, the type of patient choosing that practice shifts. That shift appears first in new patient case mix, then in elective procedure acceptance rates among existing patients, then in collections per visit, then in EBITDA margin.

The groups that move fastest through this cycle change positioning and patient discovery simultaneously. Repositioning a location without updating how that positioning reaches the local market is slow. Your patient discovery channels need to reflect the new positioning for new patients to arrive pre-sold on the higher-value service mix you are trying to build.

In The Dental Index data pattern that opened this article, the 17-location group did not reverse its insurance exit. It ran a location-level positioning audit across all 11 transitioned practices. It identified which locations had a clear local clinical identity and which were running on brand awareness alone. The three locations with the strongest local positioning held attrition below 13 percent. The eight with weakest local positioning lost between 24 and 35 percent of their active patients.

The difference was not the quality of the dentistry. It was not the fee schedule. It was whether a patient in that market had a reason to stay that the insurance discount had never been providing.

If you are running a group of 10 or more locations, look at your EBITDA variance by location this week. The outliers at the bottom are almost certainly the locations where positioning is least distinct in their local market. That variance is not a management problem or an operations problem. It is a positioning problem showing up in your financial reports.

Where Does Your Positioning Actually Reach the Patients Who Have Never Heard of You?

The Dental Index national practice audit tracked 432,000 AI dental searches per month nationally. Those are patients actively choosing a practice. They are not browsing. They are deciding. And 70 percent of dental practices are invisible to those patients at the exact moment that decision is being made.

Your locations are almost certainly in that 70 percent unless you have taken specific, deliberate steps to build AI search visibility at the location level. Most groups have not. The brand presence is often visible nationally. The location-level signal that tells AI search and Google Maps which procedures to associate with which practice is usually thin or absent. Your positioning only reaches patients if they can find you, and in 2026 that means your practice showing up in AI search and Google Maps before the practice two miles away does.

The Dental Index data found that practices with fully completed Google Business Profiles receive 7 times more AI-referred clicks than those without. For a location you are actively repositioning toward implant or cosmetic growth, that is not a technology detail. It is the mechanism through which your new positioning reaches the patients you rebuilt the location to serve. Without it, you have repositioned internally and stayed invisible externally.

For every location in your portfolio, your AI search visibility by procedure type is a measurable, auditable gap right now. It is one of the few revenue levers in a multi-site group that can be closed location by location, market by market, without a portfolio-wide initiative. The patients who will drive your highest-revenue cases next quarter are searching today. The question is whether they find your locations or the ones that have already built their positioning into their local AI search presence.